Take Solutions Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: ₹11.00 High: ₹12.00
on August 22, 2025

52 Week Range

Low: ₹6.51 High: ₹23.69
on April 1, 2025
on October 1, 2024

All-Time High: ₹308.25 on June 11, 2018

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR1.5B
EPS i 0.18
P/E Ratio (TTM) i 58.39
Forward P/E i 0.58
P/B Ratio i 7.57
PEG Ratio i -0.76
Div. Yield i N/A
ROE i 182.53%
Beta i 0.485
Debt to Equity i 0.00

Financial Highlights

Profitability

Gross Margin i N/A
Operating Margin i -1,892.68%
Profit Margin i 98,304.88%

Returns and Earnings

Return on Assets (TTM) i 102.71%
Return on Equity (TTM) i 182.53%
EBITDA i INR27.4M
Net Income (TTM) i INR26.1M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i INR0.00
Quarterly Revenue Growth (YoY) i N/A
Quarterly Earnings Growth (YoY) i N/A

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Take Solutions TAKE 1.54B Small-cap21.38%14.09%15.34%3.12%-28.34%-40.86%-55.12%-78.96%
Biocon BIOCON 486.32B Large-cap-1.32%-7.15%7.93%12.05%-2.52%2.25%17.20%-8.19%
OneSource Specialty ONESOURCE 207.95B Large-cap-1.92%-7.96%9.66%44.47%7.66%7.66%7.66%7.66%
Dishman Carbogen DCAL 41.28B Small-cap1.90%5.55%9.34%24.24%-6.01%40.10%124.96%44.59%
Zota Health Care ZOTA 34.68B Small-cap-7.15%6.84%27.96%48.45%60.58%84.94%380.00%717.38%
Panacea Biotec PANACEABIO 25.12B Small-cap-4.08%-5.81%-20.58%24.41%-8.28%101.35%200.15%149.58%

Ownership & Short Interest

Insider Ownership i 34.55%
Institutional Ownership i 0.00%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 34K
Average 90-Day Volume i 39K

Take Solutions Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Take Solutions would have performed over time.

INR
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Take Solutions reached a high of ₹23.69 (on October 1, 2024) and a low of ₹6.51 (on April 1, 2025).
Curious about Take Solutions's size and valuation? Its market capitalization stands at 1.54B. When it comes to valuation, the P/E ratio (trailing twelve months) is 58.39, and the forward P/E (looking ahead) is 0.58.
As for dividends, Take Solutions isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at Take Solutions, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Biocon
BIOCON
486.32BHealthcareBiotechnology2.25%17.20%
OneSource Specialty
ONESOURCE
207.95BHealthcareBiotechnology7.66%7.66%
Dishman Carbogen
DCAL
41.28BHealthcareBiotechnology40.10%124.96%
Zota Health Care
ZOTA
34.68BHealthcareBiotechnology84.94%380.00%
Panacea Biotec
PANACEABIO
25.12BHealthcareBiotechnology101.35%200.15%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Take Solutions's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 182.53%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at N/A.
Looking at Take Solutions's growth, its revenue over the trailing twelve months (TTM) was INR410K. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
Wondering who owns Take Solutions stock? Company insiders (like executives and directors) hold about 34.55% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.